Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s):  XRTX

Healthcare
XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance... see more

TSXV:XRTX - Post Discussion

XORTX Therapeutics Inc > BOD Wake UP, DELISTING on Nasdaq is a REALITY,, AB42-Boilers
View:
Post by SpaceLabs on Dec 02, 2021 2:51am

BOD Wake UP, DELISTING on Nasdaq is a REALITY,, AB42-Boilers

Dr.Xortx SCREWED the GRASSROOTS,, 1/12 RB and now he will REAP what he SOWED in the REDNECK COUNTRY ,,,AB42-RRuners,,, the NN Financiers in a DEVASTATING IPO on NASDAQ at a HUGE Discount showing the WEAKNESS of XRX.

FIRE Dr. Allen as our CEO and hire an APPRENTICE CEO on Nasdaq/Wall St who has Investment Firm Connections in NEW YORK or

get the MED out, fast tracked by FDA to AVOID AB42 Boilers and DELISTING on NASDAQ.
Comment by diamondlessnono on Dec 02, 2021 2:09pm
Won't DELIST.
Comment by Alex1726 on Dec 03, 2021 8:44am
It will not delist because the minimum bid to keep a nasdaq listing is $1 but will continu to fall
Comment by diamondlessnono on Dec 03, 2021 11:55am
Alittle bit lower, and i'm in.
XORTX Therapeutics Inc